Monitoring trends in longevity in the UK and their possible cause

Improvement in life expectancy in the UK is a significant strategic issue for the UK Government and the economy and is currently poorly understood. As a consequence, it is important to study both the drivers enhancing life expectancy e.g. medical  advances and social change and the inhibitors e.g. aspects of lifestyle and delays in  development and delivery of treatment interventions.

The Panel takes account of:

  • Evidence from the biomedical sciences about the ageing process;
  • Developments in epidemiology and their implications for health, morbidity and mortality;
  • Evidence about changing rates of the major causes of death;
  • Emerging clinical advances and their likely impact on longevity;
  • The capabilities of UK health institutions to implement advances in healthcare and public health;
  • The impact of social change on future life expectancy.

The Panel is unconstrained in the conduct and communication of its work by any particular commercial interest.  Its conclusions will be openly disseminated, with the intention of promoting public interest in the factors that influence life expectancy.

"Such statistics and research keep us up to date about the health and condition of the people, help to evaluate the services available to them and to plan for the future."